The estimated Net Worth of Byron Myers is at least $12.2 million dollars as of 15 March 2021. Mr. Myers owns over 7,102 units of Inogen Inc stock worth over $513,599 and over the last 11 years he sold INGN stock worth over $10,801,740. In addition, he makes $876,820 as Executive Vice President of Marketing at Inogen Inc.
Byron has made over 34 trades of the Inogen Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 7,102 units of INGN stock worth $118,035 on 15 March 2021.
The largest trade he's ever made was exercising 35,000 units of Inogen Inc stock on 17 November 2017 worth over $856,100. On average, Byron trades about 6,276 units every 47 days since 2014. As of 15 March 2021 he still owns at least 44,429 units of Inogen Inc stock.
You can see the complete history of Mr. Myers stock trades at the bottom of the page.
Byron Myers has been appointed as Executive Vice President of Marketing of the Company effective 8/17/2020., Mr. Myers is a co-founder of Inogen and has served as our Executive Vice President, Engineering since March 2014. Prior to serving in this position, Mr. Taylor served as our Vice President, Engineering from 2008 until March 2014 and as the Director of Technology with our company from 2003 to 2008. Mr. Taylor is listed as an inventor on 29 of the Company’s issued U.S. patents related to portable oxygen concentrator development. Mr. Taylor received a Bachelor of Science degree in Microbiology from the University of California, Santa Barbara.
As the Executive Vice President of Marketing of Inogen Inc, the total compensation of Byron Myers at Inogen Inc is $876,820. There are 3 executives at Inogen Inc getting paid more, with Scott Wilkinson having the highest compensation of $2,520,530.
Byron Myers is 40, he's been the Executive Vice President of Marketing of Inogen Inc since 2020. There are 16 older and 2 younger executives at Inogen Inc. The oldest executive at Inogen Inc is Benjamin Anderson-Ray, 65, who is the Independent Director.
Byron's mailing address filed with the SEC is C/O INOGEN, INC., 326 BOLLAY DRIVE, GOLETA, CA, 93117.
Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen et Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
Inogen Inc executives and other stock owners filed with the SEC include: